Skip to content

    IRONWOOD PHARMACEUTICALS (IRWD) stock price & financials

    View IRWD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+227.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $91.59M
    $90.55M
    $41.14M
    $85.24M
    $122.06M
    +33.3%
    $47.71M
    -47.3%
    $106.51M
    +158.9%
    $113.04M
    +32.6%
    Strengthening
    Operating Profit
    $25.64M
    $31.49M
    -$29.11M
    $45.32M
    $75.48M
    +194.4%
    $6.80M
    -78.4%
    $72.57M
    $79.31M
    +75.0%
    Stable
    Net Profit
    $3.65M
    $2.26M
    -$37.39M
    $23.60M
    $40.08M
    +999.3%
    -$2.28M
    -200.9%
    $40.77M
    $51.29M
    +117.3%
    Weakening
    EPS
    $0.02
    $0.01
    $-0.23
    $0.15
    $0.25
    +1150.0%
    $-0.01
    -200.0%
    $0.25
    $0.31
    +106.7%
    Weakening
    Other Income
    -$8.27M
    -$7.50M
    -$7.16M
    -$7.50M
    -$7.46M
    +9.7%
    -$6.35M
    +15.3%
    -$7.40M
    -3.3%
    -$5.58M
    +25.6%
    Strengthening
    Interest
    $9.42M
    $8.91M
    $8.07M
    $8.36M
    $8.43M
    -10.5%
    $7.89M
    -11.5%
    $9.14M
    +13.3%
    $7.20M
    -13.8%
    Weakening
    Depreciation
    Profit before Tax
    $17.37M
    $24.00M
    -$36.27M
    $37.82M
    $68.02M
    +291.6%
    $455.0K
    -98.1%
    $65.17M
    $73.73M
    +94.9%
    Stable
    MarginsOPM
    28.0%
    34.8%
    -70.8%
    53.2%
    61.8%
    +120.9%
    14.3%
    -59.0%
    68.1%
    70.2%
    +32.0%
    Weakening
    Tax
    79.0%
    90.6%
    -3.1%
    37.6%
    41.1%
    -48.0%
    600.2%
    +562.5%
    37.4%
    30.4%
    -19.1%
    Strengthening
    ReturnsROIC
    -0.2%
    -0.1%
    2.4%
    -1.5%
    -2.5%
    -999.3%
    0.1%
    -2.6%
    -209.1%
    -3.2%
    -117.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$173.17M$177.02M$362.56M$620.13M$656.20M$92.15M$88.56M$215.46M$79.13M
    Short-Term Investments
    Total Current Assets$266.44M$306.85M$495.84M$745.23M$780.63M$233.29M$182.37M$274.18M$199.20M
    Net PP&E$7.65M$30.17M$25.50M$22.93M$20.31M$18.17M$15.52M$12.75M$11.36M
    Goodwill$785.0K$785.0K
    Intangibles$3.68M$2.86M$2.04M$1.63M
    Total Assets$332.05M$402.75M$559.24M$1.13B$1.10B$471.07M$350.91M$396.90M$285.13M
    LiabilitiesTotal Current Liabilities$119.52M$40.93M$32.17M$161.70M$25.52M$276.10M$38.85M$242.22M$32.85M
    Short-Term Debt
    Long-Term Debt$430.26M$454.19M$396.25M$397.87M$198.99M
    Long-Term Leases$22.08M$20.32M$18.48M$16.60M$14.54M$12.30M$9.87M$8.58M
    Total Liabilities$528.42M$496.00M$496.60M$521.02M$448.14M$817.37M$652.24M$658.74M$446.97M
    EquityCommon Stock & APIC$154.0K$158.0K$161.0K$162.0K$154.0K$156.0K$160.0K$163.0K$165.0K
    Retained Earnings-$1.59B-$1.57B-$1.47B-$937.61M-$696.38M-$1.70B-$1.70B-$1.67B-$1.58B
    Total Equity-$196.37M-$93.25M$62.64M$605.91M$652.38M-$346.30M-$301.33M-$261.83M-$161.84M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$70.88M$10.72M$168.84M$261.89M$273.76M$183.43M$103.55M$127.04M$185.56M
    Cash from Investing$88.87M-$11.14M-$1.84M-$265.0K-$136.0K-$1.03B-$142.0K-$34.0K
    Cash from Financing$30.07M-$1.19M$18.55M-$4.55M-$237.55M$277.16M-$106.97M$216.0K
    SummaryCapital Expenditure-$351.0K-$7.19M-$1.84M-$265.0K-$136.0K-$273.0K-$142.0K-$34.0K
    Free Cash Flow-$71.23M$3.54M$166.99M$261.63M$273.63M$183.15M$103.41M$127.01M
    FCF Margin-20.5%0.8%42.9%63.2%66.6%41.4%29.4%42.9%

    Ratios